Analyze Diet
Equine veterinary journal2002; 33(7); 681-686; doi: 10.2746/042516401776249273

Evaluation of IgG concentration and IgG subisotypes in foals with complete or partial failure of passive transfer after administration of intravenous serum or plasma.

Abstract: The purpose of this study was to evaluate the ability of an equine plasma product i.v. and a concentrated serum product i.v. to deliver antibodies to 46 foals with failure of passive transfer (FPT). Treatment of FPT was as per manufacturers recommendations, using plasma (950 ml/unit) or a concentrated serum product (250 ml/unit). Significant variables affecting the 3 day post-transfusion serum immunoglobulin G (IgG) concentration of foals included body weight, pretransfusion IgG concentration, number of product units transfused, foaling season and product administered. Plasma treatment had a greater increase in post-transfusion serum IgG concentrations compared to the serum product treatment mainly because plasma contained approximately twice the amount of IgG per unit as the serum product. The change in equine influenza virus and tetanus toxoid-specific IgGa, IgGb, and IgG(T) titres was measured in foals from pretransfusion to 3 days post-transfusion. For each gram of IgG transfused, the change in antigen-specific IgG subisotypes were similar for both treatment groups. The results of this study suggest that similar foal serum IgG concentrations can be achieved 3 days post-transfusion by administering 1 unit of plasma or 2-3 units of serum product.
Publication Date: 2002-01-05 PubMed ID: 11770990DOI: 10.2746/042516401776249273Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on examining the effectiveness of equine plasma and concentrated serum products in delivering antibodies to foals (young horses) suffering from a failure of passive transfer (FPT). The study finds that while both products can deliver antibodies, plasma treatment resulted in a stronger increase in antibody concentration due to its higher IgG content.

Objective and Procedure

  • The main purpose of the study was to evaluate the capacity of an equine plasma product and a concentrated serum product to deliver antibodies to 46 foals diagnosed with failure of passive transfer (FPT). This condition refers to a foal’s inability to acquire necessary immunity components from its mother’s milk, leaving it vulnerable to various infectious agents.
  • Both plasma and concentrated serum products were administered intravenously as per the recommendations of the respective manufacturers. The quantity used was 950 ml/unit for the plasma product and 250 ml/unit for the serum product.

Variables and Results

  • Significant variables affecting the serum immunoglobulin G (IgG) concentration of foals three days post-transfusion included factors such as the body weight of the foal, the IgG concentration before transfusion, the number of product units transfused, the season during which foaling occurred, and the actual product administered. Immunoglobulin G (IgG) is the most common type of antibody found in blood circulation, they are critical for fighting bacterial and viral infections.
  • The study observed a higher increase in IgG concentrations post-transfusion in foals treated with plasma, as compared to those treated with the serum product. The plasma product contained approximately double the amount of IgG per unit relative to the serum product.

Measurement of Specific Antibodies

  • The researchers also measured the change in the titres of foal antibodies specific to equine influenza virus and tetanus toxoid, from before the transfusion to three days after the transfusion.
  • These measurements accounted for variations in IgGa, IgGb, and IgG(T) subisotypes. Subisotypes are different forms of an antibody that are produced by different classes of plasma cells and have different functions.
  • The changes in subisotype levels for each gram of IgG transfused were observed to be similar across both treatment groups.

Conclusions of the Study

  • Concluding the study, the researchers suggest similar foal serum IgG concentrations could be achieved three days post-transfusion by administering one unit of plasma or two to three units of serum product.
  • The choice between equine plasma and concentrated serum products might therefore depend on other factors, such as the specific requirements of the foal or the cost and availability of the products.

Cite This Article

APA
McClure JT, DeLuca JL, Lunn DP, Miller J. (2002). Evaluation of IgG concentration and IgG subisotypes in foals with complete or partial failure of passive transfer after administration of intravenous serum or plasma. Equine Vet J, 33(7), 681-686. https://doi.org/10.2746/042516401776249273

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 33
Issue: 7
Pages: 681-686

Researcher Affiliations

McClure, J T
  • Department of Health Management, Atlantic Veterinary College, Charlottetown, Prince Edward Island, Canada.
DeLuca, J L
    Lunn, D P
      Miller, J

        MeSH Terms

        • Animals
        • Animals, Newborn / blood
        • Animals, Newborn / immunology
        • Horse Diseases / immunology
        • Horses / blood
        • Horses / immunology
        • Immunity, Maternally-Acquired / immunology
        • Immunization, Passive / methods
        • Immunization, Passive / veterinary
        • Immunoglobulin G / administration & dosage
        • Immunoglobulin G / blood
        • Immunoglobulin Isotypes / administration & dosage
        • Immunoglobulin Isotypes / blood
        • Influenza Vaccines / administration & dosage
        • Injections, Intravenous / veterinary
        • Orthomyxoviridae Infections / immunology
        • Orthomyxoviridae Infections / veterinary
        • Tetanus / immunology
        • Tetanus / veterinary
        • Tetanus Toxoid / administration & dosage